DUBLIN , July 19, 2022 /PRNewswire/ -- The "Hypodermic Needles Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global hypodermic needles market reached a value of US$ 2.48 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 3.86 Billion by 2027 exhibiting a CAGR of 7.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Hypodermic needles refer to thin, hollow needles used with a syringe to inject substances into the body. They also assist in extracting fluids from the body, such as taking a blood sample from a vein in venipuncture. They are typically manufactured using stainless-steel tubes through the tube drawing process.
Hypodermic needles can also be utilized to provide medications that cannot be ingested orally because they cannot be absorbed easily (like insulin) or potentially harm the patient's liver. Moreover, they have an extremely smooth and sharp surface which prevents and minimizes contamination during inoculation of a sterile substrate. As a result, hypodermic needles find extensive applications in the healthcare sector and research environments requiring sterile conditions. Hypodermic needles are widely used by medical professionals, physicians, dentists, and paramedics for rapid intradermal delivery of liquids in case of emergencies, vaccination, administration of drugs, and blood sample collection, which represents the primary factor driving the market growth.
Additionally, the widespread prevalence of infections and chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has escalated the demand for vaccines and injectable drugs. Along with this, the ongoing vaccination campaigns to curb the spread of coronavirus disease (COVID-19) across the globe are catalyzing the demand for hypodermic needles. Besides this, the implementation of stringent regulations by governments of various countries that mandate the use of safety needles to prevent needle re-usage and mitigate the risk of infections is propelling the market growth.
Furthermore, several leading manufacturers are developing precision-engineered hypodermic needles to enhance patient comfort in parenteral therapies and reduce penetration resistance. They are also making heavy investments in automated systems for inspection and testing processes to meet the quality standards and ensure the safe administration of medications. Other factors, including the growing need to prevent needle-stick injuries, surging cases of blood-borne diseases, increasing blood donations, improving healthcare infrastructure, and technological advancements, are also creating a favorable market outlook.
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Cardinal Health Inc., Connecticut Hypodermics Inc., EXELINT International Co., Hi-Tech Syringes, McKesson Corporation, Medline Industries LP, Nipro Corporation, Retractable Technologies Inc., Smiths Medical Inc. (ICU Medical Inc.) and Terumo Corporation. Key Questions Answered in This Report:
How has the global hypodermic needles market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hypodermic needles market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hypodermic needles market and who are the key players?
What is the degree of competition in the industry?
Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Hypodermic Needles Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Safety Hypodermic Needles 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Non-Safety Hypodermic Needles 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Application 7.1 Drug Delivery 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Vaccination 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Blood Specimen Collection 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals and Clinics 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Ambulatory Surgical Centers 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Diabetic Patients 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Family Practices 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Psychiatrics 8.5.1 Market Trends 8.5.2 Market Forecast 8.6 Others 8.6.1 Market Trends 8.6.2 Market Forecast 9 Market Breakup by Region
10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 B. Braun Melsungen AG 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 SWOT Analysis 14.3.2 Becton Dickinson and Company 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Cardinal Health Inc. 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Connecticut Hypodermics Inc. 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.5 EXELINT International Co. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Hi-Tech Syringes 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 McKesson Corporation 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Medline Industries LP 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 SWOT Analysis 14.3.9 Nipro Corporation 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.9.4 SWOT Analysis 14.3.10 Retractable Technologies Inc. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.11 Smiths Medical Inc. (ICU Medical Inc.) 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 SWOT Analysis 14.3.12 Terumo Corporation 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.12.3 Financials 14.3.12.4 SWOT Analysis
For more information about this report visit https://www.researchandmarkets.com/r/fsehni
Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-hypodermic-needles-market-2022-to-2027---industry-trends-share-size-growth-opportunity-and-forecasts-301589121.html
Diversification isn't necessary if you know what you're doing, according to the Oracle of Omaha.
Slaying the inflation dragon isn't done with baby steps. Expect much higher interest rates as a headwind for equities.
NEW YORK—The U.S. Securities and Exchange Commission on Friday added Alibaba Group Holding to a list of Chinese companies at risk of being delisted from the U.S. exchanges if their auditors can’t be inspected before spring 2024. The move comes days after Alibaba said it would apply for a primary listing in Hong Kong, where it obtained a secondary listing in 2019. Securing a primary listing in the Asian financial hub would allow Alibaba’s shares to continue to be traded even if it is booted from the American bourse.
In this article, we discuss the 7 stocks that Cathie Wood dumped in July. If you want to see more stocks that she disposed of during this month, click Cathie Wood Dumped These 3 Stocks in July. In June, Cathie Wood’s ARK Investment Management suffered a sharp decline in assets, which was decidedly higher than […]
The company's future is in doubt after losing a key patent litigation
Yahoo Finance's Akiko Fujita discusses why Roku stock is down Friday.
British American Tobacco p.l.c.'s ( LON:BATS ) investors are due to receive a payment of £0.5445 per share on 10th of...
(Bloomberg) -- Alibaba Group Holding Ltd. has moved a step closer toward getting booted off US stock exchanges for American inspectors not being able to access to financial audits.Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekAlito Decries 'Hostility to Religion' in First Public Remarks Since Abortion Decision Rockstar Games Cleaned Up Its Frat-Boy Culture — and Grand Theft Auto, TooBiden, Xi Plan In-Person Meet as Taiwan Tensions IntensifyEuro-Zone Infla
When Elon Musk decided to terminate his $44 billion deal to purchase Twitter the social-media company sued in the Delaware Court of Chancery. Twitter is suing for “specific performance,” a rare remedy that would require Musk to complete the merger. Unfortunately for Twitter, it isn’t Elon Musk Inc. but Elon Musk the individual who offered to buy the company.
Here’s a good bit of news for retirees in 2022: you can keep more money in your tax-deferred retirement accounts.
The oil giant is expected to have made far more than twice of what it pocketed in profit a year ago.
(Bloomberg) -- With recession fears mounting—and inflation, the war in Ukraine and the lingering pandemic taking a toll—many tech companies are rethinking their staffing needs, with some of them instituting hiring freezes, rescinding offers and making rounds of layoffs.Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekAlito Decries 'Hostility to Religion' in First Public Remarks Since Abortion Decision Rockstar Games Cleaned Up Its Frat-Boy Culture — and Gran
(Bloomberg) -- Jack Ma is taking a weeks-long tour in Europe after largely disappearing from public view for almost two years, adding to signs that China’s government is easing pressure on the entrepreneur as he steps back from a business empire that had made him one of the country’s most powerful people.Most Read from BloombergRockstar Games Cleaned Up Its Frat-Boy Culture — and Grand Theft Auto, TooBiden, Xi Plan In-Person Meet as Taiwan Tensions IntensifyUS Economy Shrinks for a Second Quarte
On Novavax's (NVAX) second-quarter earnings call, investors' focus is likely to be on the sales figures of its COVID-19 vaccine.
More than a year after an activist investor-led shake-up, Exxon Mobil has ticked a lot of boxes to endear itself to its shareholders. Exxon Mobil on Friday said it generated nearly $16.9 billion in free cash flow in the second quarter, the highest since 2008 and roughly $900 million more than analysts polled by Visible Alpha had expected. Quarterly net income for both Exxon and Chevron hit a record—not entirely surprising given that Brent crude prices averaged $113.78 a barrel in the second quarter, a $12 per barrel increase compared with the first quarter.
Each of these five real estate investment trusts (REITs) currently pays a dividend of greater than 5%. For those willing to accept the risks, that’s a better yield than that of the U. S. Government 10-Year Treasury Note. Each REIT trades on the New York Stock Exchange, so plenty of information on these REITs is available from analysts at respected investment firms. Looking for ways to boost your returns? Check out Benzinga's coverage on Alternative Real Estate Investments: Exclusive Offering For
In this article, we discuss Cathie Wood’s top 10 buys in July. If you want to see more stocks that Cathie Wood bought this month, click Cathie Wood’s Top 5 Buys in July. In the beginning of July, Cathie Wood of ARK Investment Management admitted that while her predictions about inflation were wrong, the US […]
The stock market is down so far this year; despite a rally since mid-June, the S&P is still down 15% year-to-date and the NASDAQ is down 23%. Share price drops like these get investors thinking about portfolio defense, and that naturally brings them around to dividend stocks. Companies can pay out dividends annually, quarterly, or monthly. Quarterly payments are the most common, but for truly defensive investors, monthly payments offer some advantages. Chief among those is the rapid and regular
Yahoo Finance Live anchors discuss Roku earnings, which sent the stock tanking.
Higher production volumes are likely to have resulted in a significant increase in utilization rates on pipelines of Enterprise (EPD).